X0508 4 2026-02-09 0 0001625297 Indivior Pharmaceuticals, Inc. INDV 0002014866 Preblick Ryan 10710 MIDLOTHIAN TURNPIKE SUITE 125 NORTH CHESTERFIELD VA 23235 0 1 0 0 Chief Financial Officer 0 Common Stock 2026-02-10 4 A 0 37358 0 A 317940 D Performance Stock Units 0 2026-02-09 4 A 0 113510 0 A 2028-03-03 Common Stock 113510 113510 D Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer. On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person. Exhibit 24 Power of Attorney /s/Alice Givens, Power of Attorney 2026-02-12